Access to anti-retroviral drugs, female in Suriname
Suriname: Access to anti-retroviral drugs, female was 62.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Suriname, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Suriname recorded 62.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 29.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Suriname peaked at 62.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Suriname 99th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Suriname, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 2.0% | — |
| 2003 | 4.0% | +100.0% |
| 2004 | 6.0% | +50.0% |
| 2005 | 8.0% | +33.3% |
| 2006 | 12.0% | +50.0% |
| 2007 | 16.0% | +33.3% |
| 2008 | 20.0% | +25.0% |
| 2009 | 22.0% | +10.0% |
| 2010 | 24.0% | +9.1% |
| 2011 | 28.0% | +16.7% |
| 2012 | 38.0% | +35.7% |
| 2013 | 45.0% | +18.4% |
| 2014 | 48.0% | +6.7% |
| 2015 | 48.0% | +0.0% |
| 2016 | 51.0% | +6.2% |
| 2017 | 52.0% | +2.0% |
| 2018 | 53.0% | +1.9% |
| 2019 | 52.0% | -1.9% |
| 2020 | 60.0% | +15.4% |
| 2021 | 57.0% | -5.0% |
| 2022 | 53.0% | -7.0% |
| 2023 | 62.0% | +17.0% |
| 2024 | 62.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.0% | 0.0% | 22.0% | 10 |
| 2010s | 43.9% | 24.0% | 53.0% | 10 |
| 2020s | 58.8% | 53.0% | 62.0% | 5 |
Countries ranked near Suriname
More gender data for Suriname
- Child population (UN estimates and projections) 158.99 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4271 % change on previous year (2030)
- Population 506.66 (2030)
- Working-age population (UN estimates and projections) 506.66 (2030)
- Population (UN estimates and projections), annual growth rate 1.11 % change on previous year (2030)
- Age population, age 00, female, interpolated 5,273 (2025)
- Age population, age 00, male, interpolated 5,469 (2025)
- Age population, age 01, female, interpolated 5,254 (2025)
- Age population, age 01, male, interpolated 5,447 (2025)
- Age population, age 02, female, interpolated 5,239 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Suriname?
- Access to anti-retroviral drugs, female in Suriname was 62.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Suriname?
- The highest recorded value was 62.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Suriname?
- The lowest recorded value was 0.0% in 2000.
- How does Suriname rank for access to anti-retroviral drugs, female?
- Suriname ranks 99th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Suriname?
- Over the last ten years it is up 29.2%. The long-run trend across the full record is volatile.
- Where does this Suriname data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.